Opaleye Management Inc. 13D and 13G filings for Protara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2020-09-25 5:20 pm Sale |
2020-09-24 | 13D | Protara Therapeutics, Inc. TARA |
Opaleye Management Inc. | 2,508,472 23.860% |
-2,527,538![]() (-50.19%) |
Filing |